all AI news
Quest Diagnostics to acquire PathAI Diagnostics
AI – AI-TechPark ai-techpark.com
Transaction is part of wide-ranging collaboration to combine Quest’s oncology expertise and scale with PathAI’s AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced...
The post Quest Diagnostics to acquire PathAI Diagnostics first appeared on AI-TechPark.
ai artificial artificial intelligence collaboration costs dgx diagnosis diagnostic diagnostics digital digital pathology expertise global information innovations intelligence leader nyse oncology part pathology provider quality quest reduce scale services speed technology